Joint Media Call: FDA & CDC to Discuss Janssen COVID-19 Vaccine - 4/13/2021
Media Call: VRBPAC – 2/11/2022
GCP & Pharmacovigilance Compliance Symposium | D2S05 - Collaboration Between Agencies and Future...
Joint Meeting of the DSaRM and the DODAC - Day 1
Good Clinical Practice & Pharmacovigilance Compliance Symposium Day Three – AM
GCP & Pharmacovigilance Compliance Symposium | D3S00 – Day Three Opening Remarks
GCP & Pharmacovigilance Compliance Symposium | D1S00 – Day One Opening Remarks and Keynote Address
BREAKING NEWS: RFK Jr. Announces FDA Will Remove Warnings On Hormone Replacement Menopause Treatment
Good Clinical Practice & Pharmacovigilance Compliance Symposium Day One – AM
Media Call: Second COVID-19 Vaccine – 12/18/2020
Postmarketing Safety and Surveillance of Generic Drugs Update
February 15, 2022 Joint Meeting of the AADPAC-DSaRM
Good Clinical Practice & Pharmacovigilance Compliance Symposium Day Three – PM
GCP & Pharmacovigilance Compliance Symposium | D1S05 – Day One Q&A Panel Discussion
Media Call: Third COVID-19 Vaccine – 2/27/2021
Good Clinical Practice & Pharmacovigilance Compliance Symposium Day Two – PM
Good Clinical Practice & Pharmacovigilance Compliance Symposium Day Two – AM
FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine - 4/23/2021
Interview with Janet Woodcock | FDA Center for Drug Evaluation
NYT: FDA & CDC to stop using Johnson & Johnson vaccine
